Excimer Light Versus Blue Light in Acne
Not Applicable
Not yet recruiting
- Conditions
- Acne Vulgaris
- Registration Number
- NCT06725303
- Lead Sponsor
- Cairo University
- Brief Summary
The aim is to assess the efficacy and safety of Excimer Light versus blue light in the treatment of inflammatory acne.
- Detailed Description
The use of new light energy in inflammatory acne
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 24
Inclusion Criteria
- Patients with mild to moderate inflammatory acne lesions
Exclusion Criteria
-
Pregnancy during the first trimester
- Female patients with a medical history of PCO
- Topical and systemic treatment within the last month and systemic retinoids for 6 months
- Patients on systemic steroid treatment or hormonal therapy
- Severe systemic illness or malignancy
- Photosensitivity
- Scarring acne vulgaris
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Number of comedones, papules and pustules 2 months number of lesions
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie Excimer Light's anti-inflammatory effects in acne vulgaris compared to blue light therapy?
How does Excimer Light compare to standard-of-care topical retinoids in treating inflammatory acne vulgaris?
Which biomarkers (e.g., IL-1α, sebum levels) predict response to split-face light therapy in acne patients?
What are the differential adverse event profiles of Excimer vs. blue light in facial acne treatment?
How do photodynamic therapy combinations enhance Excimer Light efficacy for nodular acne vulgaris?